Melanocortin receptor agonists, penile erection, and sexual motivation: Human studies with Melanotan II

  • Wessells H
  • Levine N
  • Hadley M
 et al. 
  • 12

    Readers

    Mendeley users who have this article in their library.
  • 79

    Citations

    Citations of this article.

Abstract

We review our experience with Melanotan II, a non-selective melanocortin receptor agonist, in human subjects with erectile dysfunction (ED). Melanotan II was administered to 20 men with psychogenic and organic ED using a double-blind placebo-controlled crossover design. Penile rigidity was monitored for 6 h using RigiScan. Level of sexual desire and side effects were reported with a questionnaire. In the absence of sexual stimulation, Melanotan II led to penile erection in 17 of 20 men. Subjects experienced a mean of 41 min Rigiscan tip rigidity>80%. Increased sexual desire was reported after 13/19 (68%) doses of Melanotan II vs 4/21 (19%) of placebo (P

Author-supplied keywords

  • Impotence
  • MSH
  • Penile erection
  • Sex behavior

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document

Authors

  • H. Wessells

  • N. Levine

  • M. E. Hadley

  • R. Dorr

  • V. Hruby

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free